Literature DB >> 19454089

Colorectal cancer: screening.

Carmen Lynn Lewis1.   

Abstract

INTRODUCTION: Nearly two thirds of colorectal cancers occur in the rectum or sigmoid colon. It is the third most common cancer in resource-rich countries, accounting for about 20,000 deaths each year in the UK, and 60,000 each year in the USA. METHODS AND OUTCOMES: We conducted a systematic review and aimed to answer the following clinical question: What are the effects of screening for colorectal cancer? We searched: Medline, Embase, The Cochrane Library and other important databases up to November 2006 (BMJ Clinical evidence reviews are updated periodically, please check our website for the most up-to-date version of this review). We included harms alerts from relevant organisations such as the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA).
RESULTS: We found 19 systematic reviews, RCTs, or observational studies that met our inclusion criteria. We performed a GRADE evaluation of the quality of evidence for interventions.
CONCLUSIONS: In this systematic review we present information relating to the effectiveness and safety of the following interventions: colonoscopy, computed tomography colography, double contrast barium enema, faecal occult blood testing, flexible sigmoidoscopy.

Entities:  

Mesh:

Year:  2007        PMID: 19454089      PMCID: PMC2943786     

Source DB:  PubMed          Journal:  BMJ Clin Evid        ISSN: 1462-3846


  21 in total

1.  Does publicity about cancer screening raise fear of cancer? Randomised trial of the psychological effect of information about cancer screening.

Authors:  J Wardle; T Taylor; S Sutton; W Atkin
Journal:  BMJ       Date:  1999-10-16

2.  Effect of faecal occult blood screening on mortality from colorectal cancer: results from a randomised controlled trial.

Authors:  J H Scholefield; S Moss; F Sufi; C M Mangham; J D Hardcastle
Journal:  Gut       Date:  2002-06       Impact factor: 23.059

3.  The effect of fecal occult-blood screening on the incidence of colorectal cancer.

Authors:  J S Mandel; T R Church; J H Bond; F Ederer; M S Geisser; S J Mongin; D C Snover; L M Schuman
Journal:  N Engl J Med       Date:  2000-11-30       Impact factor: 91.245

4.  Meta-analysis: computed tomographic colonography.

Authors:  Brian P Mulhall; Ganesh R Veerappan; Jeffrey L Jackson
Journal:  Ann Intern Med       Date:  2005-04-19       Impact factor: 25.391

5.  Population-based surveillance by colonoscopy: effect on the incidence of colorectal cancer. Telemark Polyp Study I.

Authors:  E Thiis-Evensen; G S Hoff; J Sauar; F Langmark; B M Majak; M H Vatn
Journal:  Scand J Gastroenterol       Date:  1999-04       Impact factor: 2.423

6.  Screening for colorectal cancer reduces emergency admissions.

Authors:  J H Scholefield; M H Robinson; C M Mangham; J D Hardcastle
Journal:  Eur J Surg Oncol       Date:  1998-02       Impact factor: 4.424

7.  Randomized study of biennial screening with a faecal occult blood test: results after nine screening rounds.

Authors:  O Kronborg; O D Jørgensen; C Fenger; M Rasmussen
Journal:  Scand J Gastroenterol       Date:  2004-09       Impact factor: 2.423

Review 8.  Screening for colorectal cancer in adults at average risk: a summary of the evidence for the U.S. Preventive Services Task Force.

Authors:  Michael Pignone; Melissa Rich; Steven M Teutsch; Alfred O Berg; Kathleen N Lohr
Journal:  Ann Intern Med       Date:  2002-07-16       Impact factor: 25.391

Review 9.  Colorectal cancer screening: scientific review.

Authors:  Judith M E Walsh; Jonathan P Terdiman
Journal:  JAMA       Date:  2003-03-12       Impact factor: 56.272

10.  Baseline findings of the Italian multicenter randomized controlled trial of "once-only sigmoidoscopy"--SCORE.

Authors:  Nereo Segnan; Carlo Senore; Bruno Andreoni; Hugo Aste; Luigina Bonelli; Cristiano Crosta; Roberto Ferraris; Stefano Gasperoni; Angelo Penna; Mauro Risio; Francesco Paolo Rossini; Stefania Sciallero; Marco Zappa; Wendy S Atkin
Journal:  J Natl Cancer Inst       Date:  2002-12-04       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.